FILE - This Thursday, Dec. 18, 2014, file photograph, shows a sign at the Merck company facilities in Kenilworth, New Jersey. Britain said Monday Nov. 27, 2017, that two major drugs companies plan new research facilities that will bring 1,750 jobs to Britain, part of plans to boost the country's sagging productivity after Brexit. U.S. drug-maker Merck, known internationally as MSD, will open a research hub in London, creating 950 jobs, and German life sciences firm Qiagen is planning a genomics and diagnostics campus in Manchester, northwest England, creating as many as 800 skilled jobs. (AP Photo/Mel Evans, File)
Featured Photo Galleries
